Waters Co. (NYSE:WAT) Receives Average Rating of “Hold” from Brokerages

Waters Co. (NYSE:WAT) has been assigned a consensus rating of “Hold” from the fifteen research firms that are covering the firm, Marketbeat reports. Five research analysts have rated the stock with a sell recommendation, eight have given a hold recommendation and one has assigned a buy recommendation to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $210.54.

WAT has been the topic of a number of research reports. Cleveland Research cut Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. Bank of America cut Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. ValuEngine cut Waters from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Zacks Investment Research upgraded Waters from a “sell” rating to a “hold” rating and set a $217.00 price target on the stock in a research report on Wednesday, May 22nd. Finally, UBS Group lowered their price target on Waters from $248.00 to $230.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 24th.

NYSE WAT traded up $1.87 during trading on Friday, hitting $201.91. The company’s stock had a trading volume of 16,907 shares, compared to its average volume of 581,731. The company has a current ratio of 2.65, a quick ratio of 2.07 and a debt-to-equity ratio of 2.00. The business’s 50 day moving average is $214.55. The firm has a market cap of $13.35 billion, a price-to-earnings ratio of 24.31, a P/E/G ratio of 2.30 and a beta of 1.07. Waters has a 52 week low of $167.93 and a 52 week high of $255.21.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.11 by $0.03. The business had revenue of $599.20 million for the quarter, compared to analysts’ expectations of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. Waters’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the business posted $1.95 earnings per share. As a group, analysts predict that Waters will post 9.01 earnings per share for the current year.

A number of large investors have recently made changes to their positions in WAT. Compagnie Lombard Odier SCmA acquired a new position in Waters in the second quarter worth $37,000. Massey Quick Simon & CO. LLC acquired a new position in Waters in the first quarter worth $43,000. CSat Investment Advisory L.P. boosted its stake in Waters by 212.5% in the second quarter. CSat Investment Advisory L.P. now owns 225 shares of the medical instruments supplier’s stock worth $48,000 after purchasing an additional 153 shares in the last quarter. Financial Gravity Wealth Inc. acquired a new position in Waters in the first quarter worth $63,000. Finally, Thor Advisors LLC acquired a new position in Waters in the first quarter worth $64,000. Hedge funds and other institutional investors own 96.08% of the company’s stock.

About Waters

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

See Also: FAANG Stocks

Analyst Recommendations for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.